Open original FDA record ↗Recall record
- FDA identifier
- Z-1798-2021
- Company in FDA record
- Smiths Medical ASD Inc.
- FDA classification date
- Jun 10, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Specific models and lot numbers of the Jelco Hypodermic Needle-Pro Fixed Needle Insulin Syringe 29Gx1/2 odd number line graduation markings on the syringe barrel were skewed approximately 20 degrees upward.
Source facts
- Action
- The firm initiated the recall on May 17, 2021 by email. The firm is seeking the removal of the product down to the consumer level. For assistance ease contact Novasyte using the Email: smithsmedical-Jelco2021@novasyte.com The firm later realized they failed to include lot #40140906 for model #4429-1 and issued a second letter which was dated 5/27/2021 to customers involved in the first notification where this lot was excluded in the letter, as well as to new consignees who received the affected lot.
- Initiated
- 2021-05-17
- Root cause
- Process control
- Terminated
- 2023-10-11
- Distribution
- Worldwide distribution - US Nationwide and the countries of UK, Spain.
- Recall number
- Z-1798-2021
- Recall status
- Terminated
- CDRH record ID
- 187480
- FDA classified
- 2021-06-10
- Recall event number
- 87945